Changes in cardiovascular biomarkers in HIV-infected patients switching from ritonavir-boosted protease inhibitors to raltegravir-Reference-Cited by-同舟云学术

Changes in cardiovascular biomarkers in HIV-infected patients switching from ritonavir-boosted protease inhibitors to raltegravir

Published:2012-11-28 Issue:18 Volume:26 Page:2315-2326
ISSN:0269-9370
Container-title:AIDS
language:en
Short-container-title:

Author:

Martínez Esteban,D’Albuquerque Polyana M.,Llibre Josep M.,Gutierrez Felix,Podzamczer Daniel,Antela Antonio,Berenguer Juan,Domingo Pere,Moreno Xabier,Perez Ignacio,Pich Judit,Gatell José M.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Infectious Diseases,Immunology,Immunology and Allergy

Reference36 articles.

1. Protease inhibitors and cardiovascular outcomes in patients with HIV-1.;Holmberg;Lancet,2002

2. Class of antiretroviral drugs and the risk of myocardial infarction.;N Engl J Med,2007

3. Impact of individual antiretroviral drugs on the risk of myocardial infarction in human immunodeficiency virus-infected patients: a case-control study nested within the French Hospital Database on HIV ANRS cohort CO4.;Lang;Arch Intern Med,2010

4. Epidemiological evidence for cardiovascular disease in HIV-infected patients and relationship to highly active antiretroviral therapy.;Currier;Circulation,2008

5. Progression of carotid intima-media thickness in a contemporary human immunodeficiency virus cohort.;Baker;Clin Infect Dis,2011

Cited by 116 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Serum uric acid and high-sensitivity C-reactive protein levels among people living with HIV on dolutegravir and ritonavir-boosted atazanavir-based antiretroviral therapy: a comparative cross-sectional study;Frontiers in Medicine;2024-07-17

2. Cardiac and Renal Comorbidities in Aging People Living With HIV;Circulation Research;2024-05-24

3. Inflammation in HIV and Its Impact on Atherosclerotic Cardiovascular Disease;Circulation Research;2024-05-24

4. Serum Lipid Profiles, Blood Glucose, and High-Sensitivity C-Reactive Protein Levels Among People Living with HIV Taking Dolutegravir and Ritonavir-Boosted Atazanavir-Based Antiretroviral Therapy at Jimma University Medical Center, Southwest Ethiopia, 2021;HIV/AIDS - Research and Palliative Care;2024-02

5. Integrase inhibitors: current protagonists in antiretroviral therapy;Immunotherapy;2023-12